TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Biomérieux Sweden AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
30,270
|
29,513
|
27,961 |
| Financial expenses |
5
|
1
|
51 |
| Earnings before taxes |
811
|
490
|
365 |
| EBITDA |
996
|
633
|
678 |
| Total assets |
11,959
|
12,238
|
10,898 |
| Current assets |
11,095
|
11,221
|
9,719 |
| Current liabilities |
8,131
|
7,681
|
6,090 |
| Equity capital |
1,282
|
2,139
|
2,725 |
| - share capital |
44
|
45
|
45 |
| Employees (average) |
34
|
31
|
27 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
10.7%
|
17.5%
|
25.0% |
| Turnover per employee |
890
|
952
|
1,036 |
| Profit as a percentage of turnover |
2.7%
|
1.7%
|
1.3% |
| Return on assets (ROA) |
6.8%
|
4.0%
|
3.8% |
| Current ratio |
136.5%
|
146.1%
|
159.6% |
| Return on equity (ROE) |
63.3%
|
22.9%
|
13.4% |
| Change turnover |
1,760
|
1,470
|
-1,517 |
| Change turnover % |
6%
|
5%
|
-5% |
| Chg. No. of employees |
3
|
4
|
0 |
| Chg. No. of employees % |
10%
|
15%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.